April 23, 2020 / 6:02 AM / a month ago

BRIEF-Vistin Pharma Q1 Net Loss At NOK 130.8 Mln

April 23 (Reuters) - Vistin Pharma ASA:

* 45% INCREASE IN REVENUE AND A RECORD QUARTERLY RESULT OF 14.2 MILLION FOR PHARMACEUTICAL BUSINESS IN Q1

* NET LOSS FOR PERIOD ENDED AT NOK 130.8 MILLION (2.0), WHICH INCLUDED LOSS OF CLOSING OIL DERIVATIVE PORTFOLIO

* Q1 REVENUE NOK 61.4 MILLION VERSUS NOK 42.2 MILLION YEAR AGO

* BOARD WILL PROPOSE TO PAY A DIVIDEND OF NOK 1 PER SHARE TO ITS SHAREHOLDERS

* DEMAND FOR METFORMIN IS STILL HIGH AND IS CURRENTLY NOT AFFECTED BY THE CORONA EPIDEMIC Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below